If you liked this article you might like

Cramer: This Drug Rally Is No Longer 'Trumped Up'
Jim Cramer Is Passing on Valeant Ahead of Earnings
What Jim Cramer Expects From Valeant Pharmaceuticals' Results on Tuesday
Cramer: Buyers for Bristol-Myers Are Few and Far Between